22 reports

It was approved in 1973 for the treatment of asthma, COPD and bronchospasm in the US and EU.

  • Tuberculosis
  • World
  • Market Size
  • Actelion Ltd
  • Pfizer Inc.
  • Technology Development

The clinic applications of the said new drug at Beijing XiYuan Hospital have confirmed its numerous pharmacological functions such as bacteria resistance; cough relieving, asthma suppressing, phlegm dissolving and immunity enhancing.

  • Tuberculosis
  • China
  • Demand
  • Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd
  • Technology Development

The clinic applications of the said new drug at Beijing XiYuan Hospital have confirmed its numerous pharmacological functions such as bacteria resistance; cough relieving, asthma suppressing, phlegm dissolving and immunity enhancing.

  • Tuberculosis
  • China
  • Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd
  • Shenyang Shuangding Pharmaceutical Co., Ltd.
  • RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DISEASE, 2016 VS. 2021
  • THE TUBERCULOSIS DISEASE SEGMENT TO DOMINATE THE RESPIRATORY

THE GLOBAL ASTHMA REPORT 2014 BY THE GLOBAL ASTHMA NETWORK (GAN) STATED THAT AROUND ## MILLION PEOPLE GLOBALLY WERE SUFFERING FROM ASTHMA IN 2012.

  • Tuberculosis
  • North America
  • United States
  • Market Size
  • Alere Inc.

NO has a solid place in asthma management.

  • Drug Test
  • Tuberculosis
  • United States
  • Alere Inc.
  • Dräger Group

CS-## was under development for the treatment of asthma and chronic obstructive pulmonary disease (COPD).

  • Breast Cancer
  • Monoclonal Antibody
  • Therapy
  • Tuberculosis
  • Daiichi Sankyo Company
  • QURETECH BIO AB
  • TUBERCULOSIS - PIPELINE BY QURETECH BIO AB, H2 2017

The company is developing products for the treatment of atopic dermatitis; extensively drug-resistant tuberculosis (XDR)/ multi drug resistant (MDR)/ totally drug resistant (TDR) tuberculosis (TB); asthma and cancer.

  • Pathology
  • Tuberculosis
  • Vaccine
  • World
  • TB Drug Development, Inc.

It is also developing new approaches to the treatment of asthma.

  • Medical Supply
  • Tuberculosis
  • United States
  • M&A
  • Cepheid
  • 4.2.2 MRSA

PLOS ONE; ##(##): ##-## Fair RJ and Tor Y (2014).

  • Anti-Infective
  • Therapy
  • Tuberculosis
  • World
  • Deals & Alliance

Mundipharma Mundipharma Medical Company (MMCO) is a pharmaceutical company whose core areas are pain management and palliative care, disinfection and wound treatment and the treatment of asthma.

  • Tuberculosis
  • Belgium
  • United States
  • Company
  • Janssen Biotech, Inc.
  • TUBERCULOSIS FEATURED NEWS & PRESS RELEASES

Its KETAS is a phosphodiesterase inhibitor agent for ameliorating bronchial asthma and cerebro-vascular disorders.

  • Biotech
  • Tuberculosis
  • United States
  • Company
  • Product Initiative
  • Mycobacterium tuberculosis Protein Ag85A - Featured News & Press Releases

The difficulty of this task is one reason why there has not been a new TB vaccine since BCG was developed more than ## years ago, but one is still urgently needed and I' m not about to give up now. "

  • Tuberculosis
  • Vaccine
  • South Africa
  • World
  • Product Initiative
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database

The prominent features of this report are - ##.

  • Clinical Trial
  • Infectious Disease
  • Pharmaceutical
  • Tuberculosis
  • World
  • Clinical Trial profile. 577 Trial Title
  • Clinical Trial profile. 572 Trial Title

The prominent features of this report are - ##.

  • Anti-Infective
  • Clinical Trial
  • Infectious Disease
  • Tuberculosis
  • World
  • QURIENT CO LTD
  • TUBERCULOSIS - PIPELINE BY QURIENT CO LTD, H1 2018

It is also developing new approaches to the treatment of asthma.

  • Pathology
  • Tuberculosis
  • Vaccine
  • United States
  • TB Drug Development, Inc.
  • Sequella Enters Into Licensing Agreement With Maxwell Biotech Venture Fund For SQ109

Maxwell Biotech is managed by Maxwell Asset Management and invests in the pharmaceutical and medical device companies focusing on the therapeutic areas such as oncology, urology, infections, asthma and cardiology.

  • Tuberculosis
  • United States
  • Company
  • Deals & Alliance
  • GlobalData's company

It was also under development for asthma.

  • Blood Disease
  • Therapy
  • Tuberculosis
  • United States
  • AstraZeneca PLC

As of February 2012, it was in Phase II for asthma.

  • Cancer
  • Targeted Therapy
  • Therapy
  • Tuberculosis
  • Novartis AG

To u. ##-##.

  • Infectious Disease
  • Therapy
  • Tuberculosis
  • United States
  • Sanofi S.A.
  • Syntrix Biosystems, Inc. - Pipeline by Indication, 2015

Syntrix Biosystems, Inc. is developing of SX-## for the treatment of severe asthma.

  • Tuberculosis
  • Turkey
  • United States
  • Company Operations
  • Syntrix Biosystems, Inc.

The company is developing a pipeline of novel therapies to treat serious diseases such as chronic obstructive pulmonary disease (COPD), severe steroid-insensitive asthma, allergic asthma, and cystic fibrosis (CF).

  • Healthcare
  • Hospital
  • Pharmaceutical
  • Tuberculosis
  • BioFocus DPI Limited

UPDATE ON SOUTH AFRICA' S BURDEN OF DISEASE ##.

  • Healthcare
  • Hospital
  • Tuberculosis
  • South Africa
  • Netcare Limited